Sun Biomedical Nominated for Zloty OTIS Confidence Award

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) December 15, 2008 -- Blackwood, NJ, December 2008—Sun Biomedical Laboratories Inc. (SBL) was recently nominated for the Zloty OTIS Prize, awarded by Polish consumers to their most trusted pharmaceutical products. The company’s popular OraLine® Saliva Drug Screen device is the product being nominated. OraLine is used to test the presence of drug abuse on the spot and get accurate results within ten minutes.

1

Sun Biomedical Nominated for Zloty OTIS Confidence Award

Welcome visit Our WebSite:

http://www.sunbiomed.com

The “Zloty OTIS” or Gold Otis prizes are awarded for products that have the greatest trust among Polish consumers. The award has been active since 2004. Hundreds of products representing thirty-eight therapeutic categories from almost one hundred pharmaceutical companies take part in the contest. Zloty OTIS administrators require that the “Confidence Prize” fulfills three functions: educational, social and consumer.
“We’d like to thank our distribution partner in Poland, TOP-MED, for supporting our nomination for this prestigious award,” stated Jack Kerins, CEO Sun Biomedical Laboratories. “We’ve been working with TOP-MED and are very pleased that OraLine has already gained so much popularity with Polish consumers.”

Manufactured in the U.S. from premium membranes, the OraLine Saliva Drug Screen is an extremely accurate immunoassay designed to detect the presence of several illicit drugs in human saliva at levels equal to or greater than the cut-off level indicated. Drugs detected include: marijuana, cocaine, methamphetamines, and opiates/morphine/heroin. The company has recently released an advanced OraLine8 version at the Medica 2008 conference last month.

About Sun Biomedical Laboratories, Inc.

Sun Biomedical Laboratories, Inc. produces both urine and saliva based drugs of abuse testing devices at its main facility in Blackwood, New Jersey. The company has established an industry benchmark with the most sensitive saliva drugs of abuse testing device available on the market today. The company also has a portfolio of research into the use of saliva as a diagnostic medium for other disease states that provide the foundation for continued research and development and a broader portfolio of point of care testing devices. The Company, founded in 1993, is an operating unit of Sun Biomedical Limited, a public company listed on the Australian Stock Exchange (ASX) under the symbol "SBN". For more information about Sun Biomedical Laboratories and its products, contact us at 888-440-8388 or visit www.sunbiomed.com.
###

More information can be found online at http://www.sunbiomed.com